You can buy or sell BSTC and other stocks, options, ETFs, and crypto commission-free!
BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. Read More The company was founded in 1990 and is headquartered in Lynbrook, NY.
Lynbrook, New York
52 Week High
52 Week Low
Yahoo FinanceMay 12
Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp.
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent?
What's in Store for BioSpecifics (BSTC) This Earnings Season?
Shares of BioSpecifics Technologies Corp. BSTC have increased 9.7% year to date compared with the industry 's growth of 10.9%. In the las t report ed quarter, the company's earnings beat the Zacks Consensus Estimate. Moreover, BioSpecifics' earnings beat the Zacks Consensus Estimate in two of the trailing four quarters, while missed in one, with the average positive surprise being 12.46%. Let's see how things are shaping up prior to the announcement of the upcoming quarterly results. Factors Likely to Im...
$0.62 per share
$0.60 per share